Company / Current Assets per Share
Anika Therapeutics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7.17
FY2025
5-year range
$7.17 / $11.76
FY2021-FY2025
Trend
-7.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 6 consecutive years, from $16.49 in FY2019 to $7.17 in FY2025.
Based on SEC 10-K filings.
7.17 in FY2025 with a 5-year CAGR of -15.2%.
Declined from $11.17 to $7.17 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -15.2%
- 5-Year CAGR
- -15.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- Anika Therapeutics, Inc.'s current assets per share has declined for 6 consecutive years.
- In FY2025, current assets per share decreased 7.5% year-over-year.
- Peak current assets per share was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.17 | -7.5% |
| FY2024 | $7.75 | -30.6% |
| FY2023 | $11.17 | -4.9% |
| FY2022 | $11.74 | -0.2% |
| FY2021 | $11.76 | -28.2% |
| FY2020 | $16.38 | -0.7% |
| FY2019 | $16.49 | +19.3% |
| FY2018 | $13.82 | -2.0% |
| FY2017 | $14.11 | +24.4% |
| FY2016 | $11.33 | -4.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026